Last updated 7 months ago

Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

118 patients around the world
Available in Argentina, United States
GlaxoSmithKline
4Research sites
118Patients around the world
This study is for people with
Head and neck cancer
Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Exelsus - Oncología Clínica - Tucumán
Recruiting
Balcarce 648 PB - San Miguel de Tucumánhttps://www.exelsusoncologia.com/
Instituto de Diagnóstico e Investigaciones Metabólicas - IDIM - sede centro - CABA
Instituto de Diagnóstico e Investigaciones Metabólicas - IDIM - sede centro - CABA
Recruiting
Libertad 836 - Libertad 836, Ciudad de Buenos Aireswww.idim.com.ar/
Fundación Centro de Medicina Nuclear y Molecular Entre Ríos - CEMENER
Recruiting
Camino De La Cuchilla 595, Oro Verde, Entre Ríoshttps://www.respirarparana.com.ar/
Centro de Investigaciones Clínicas - IESR - Rosario, Santa Fe
Centro de Investigaciones Clínicas - IESR - Rosario, Santa Fe
Recruiting
España 931, Rosario, Santa Fe
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy